[Source: Genome Web News] – After several years of silence, bioinformatics firm Omicia is moving into the limelight.
Earlier this month, Omicia was named as a partner in the Cancer Genomic Care Alliance, a cancer genome sequencing project spearheaded by Life Technologies. The partners in the alliance, who include the Fox Chase Cancer Center, Scripps Genomic Medicine, the Translational Genomics Research Institute, and US Oncology, plan to assess the usefulness of whole-genome sequencing data in making individualized cancer treatment decisions (In Sequence 06/08/2010 and PGx Reporter 6/10/2010).
For more information: Omicia to Put Annotation Tools To Work Analyzing Sequence Data for Genomic Cancer Care Alliance